Navigation Links
Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
Date:2/3/2009

The Company has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine), and it has advanced AZ-104 (Staccato loxapine) into Phase 2b testing, both product candidates being developed for the acute treatment of migraine headache. AZ-002 (Staccato alprazolam) has completed Phase 1 testing and a Phase 2a proof-of-concept clinical trial. Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza, is available online at http://www.alexza.com.

Safe Harbor Statement

The anticipated presentation will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or oth
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. Signalife Provides Corporate Update
5. Biomira Announces Plan to Reincorporate in the United States
6. Pressure BioSciences, Inc. Provides Corporate Update
7. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
8. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
9. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Milwaukee, Wisc. (PRWEB) May 21, 2013 ... equipment parts distributor , will be exhibiting for ... the Advancement of Medical Instrumentation (AAMI) 2013 Conference ... manage, purchase, support, distribute, and manufacture healthcare technologies. ... 1-3 in Long Beach, California. , The ...
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
(Date:5/21/2013)... May 21, 2013 Smarter Security, Inc., ... solutions, today announced that Genzyme, a Sanofi company and ... Door Detective® CL for a multi-use facility in the ... four other Genzyme buildings, this latest order underscores the ... tailgate detection device improving doorway access control. ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... 20 Turtle Island Soup has launched ... with ingredients shown to have,important health benefits, ... The new Souper Food soups are ... 6086),( http://www.ganedenlabs.com/ourScience.html ), a probiotic that has ...
... from Phase One of Two-Phase Examination of U.S. Asthma ... 20 /PRNewswire-FirstCall/,-- Nearly half of adult Americans with asthma ... responded to a nationally representative survey do,not have their ... was presented today at the International Conference of the ...
... affiliations, Novation represents 49 percent of admissions and ... 52 percent of total surgeries in the United States, ... announced it has signed a contract with Novation, the,industry,s ... (UHC) and Provista, LLC. Through its,affiliations, Novation represents 49 ...
Cached Biology Technology:Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 3Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 2Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 3Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization 2Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization 3Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization 4
(Date:5/20/2013)... National Science Foundation (NSF) planning grant will help establish ... joint program of the University of Illinois at Urbana-Champaign ... "CARD will be devoted to research in drying moist, ... forestry and paper products; chemical products; textiles; and biopharmaceuticals," ... food science and human nutrition and the Illinois site ...
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...
Breaking Biology News(10 mins):NSF approves planning grant for Center for Advanced Research in Drying 2Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
... a castle gate, multiple genetic defenders cooperate to protect ... new study. Powdery mildew is a common fungal infection ... many crops such as barley and wheat, and horticultural ... Shauna Somerville and Mónica Stein of the Carnegie Institution's ...
... fingerprints and march to the beat of subtly ... bioengineering researchers at the University of California, San ... the underlying sources of variation at the basic ... and variations between identical cells. , "Scientists might ...
... ingredient, tetrahydrocannabinol--has a well-documented tendency to stimulate ... property to cannabinoid receptors in the brain, ... neural circuitry underlying this effect. , Understanding ... blocking the cannabinoid receptor, CB1, offers a ...
Cached Biology News:Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3Researchers quantify more noise in gene expression 2Researchers quantify more noise in gene expression 3Machinery of the 'marijuana munchies' 2
Carrier-Free Recombinant Human Flt-3/Flk-2 Ligand (Flt3/Flk2 Ligand, Flt3L, Flt3-L, Flk2L, Flk2-L) 100 ug...
... Antitumour agent and DNA-topoisomersae II inhibitor (IC50 ... C 29 H 32 O ... 588.55658 Store at: ... Solubility: Soluble to ...
NAP-2 (5C7)...
golgi reassembly stacking protein 2, 55kDa...
Biology Products: